Table 2.
Experiment 1 | Experiment 2 | |||||||
---|---|---|---|---|---|---|---|---|
BRCA Gist | NCI | Control | Grand Mean | BRCA Gist | NCI | Control | Grand Mean | |
I. Breast Cancer & Genetic Risk | 78%* (24) [−.583] <−.745> | 67% (23) [−.730] <.237> | 43% (26) [.106] <.048> | 62% (26) [−.219] <−.743> | 79%* (21) [−1.319] <1.319> | 68% (17) [−.680] <.797> | 56% (18) [−.475] <.059> | 68% (21) [−.548] <−.126> |
II. Risk Factors and Risk Estimation | 69%† (20) [−.553] <−.130> | 67% (21) [−.503] <−.290> | 56% (21) [−.409] <−.133> | 64% (21) [−.448] <−.257> | 69%† (19) [−.816] <.286> | 67% (16) [−.404] <.350> | 53% (20) [−.039] <−.746> | 63% (20) [−.467] <−.443> |
III. Mutations & Genetic Testing | 78%* (17) [−1.154] <1.206> | 69% (13) [−.348] <−.190> | 59% (16) [.026] <−.325> | 69% (17) [−.445] <−.081> | 77%* (20) [−1.320] <1.888> | 70% (16) [−.687] <.205> | 55% (18) [−.345] <.069> | 68% (20) [−.592] <−.043> |
IV. Consequences of Genetic Testing | 83%* (20) [−1.675] <3.365> | 72% (20) [−.616] <−.524> | 68% (18) [−.718] <.764> | 75% (20) [−.790] <.299> | 70%* (17) [−1.266] <1.771> | 61% (17) [−.586] <.205> | 57% (16) [−.160] <−.424> | 63% (18) [−.570] <−.208> |
Total Declarative Knowledge Test | 74%* (16) [−1.17] <.765> | 67% (14) [−.712] <.066> | 56% (13) [−.422] <.015> | 66% (15.6) [−.401] <−.500> | 75%* (17) [−1.479] <2.593> | 67% (14) [−.733] <.848> | 55% (15) [−.585] <.111> | 66% (16.3) [−.574] <.059> |
Note. Standard deviations are in parentheses, skew in brackets, and kurtosis in angle brackets.
BRCA Gist > NCI Web and Control, p < 0.0001.
BRCA Gist > Control, p < 0.001.